Product NDC: | 24562-001 |
Proprietary Name: | Fludeoxyglucose |
Non Proprietary Name: | Fludeoxyglucose F-18 |
Active Ingredient(s): | 300 mCi/mL & nbsp; Fludeoxyglucose F-18 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24562-001 |
Labeler Name: | Biomedical Research Foundation of Northwest Louisiana |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20111212 |
Package NDC: | 24562-001-30 |
Package Description: | 30 mL in 1 VIAL, GLASS (24562-001-30) |
NDC Code | 24562-001-30 |
Proprietary Name | Fludeoxyglucose |
Package Description | 30 mL in 1 VIAL, GLASS (24562-001-30) |
Product NDC | 24562-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fludeoxyglucose F-18 |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111212 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Biomedical Research Foundation of Northwest Louisiana |
Substance Name | FLUDEOXYGLUCOSE F-18 |
Strength Number | 300 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |